These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 31579944)

  • 1. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
    Shi Y; Li J; Chen H; Hu Y; Tang L; Wang Y; Zang X; Ma X; Huang G; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Zhuang S; Liu N
    J Pathol; 2022 Oct; 258(2):164-178. PubMed ID: 35792675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
    Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
    Zhou X; Zang X; Guan Y; Tolbert T; Zhao TC; Bayliss G; Zhuang S
    Cell Death Dis; 2018 Oct; 9(11):1067. PubMed ID: 30341286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.
    Wan SS; Pan YM; Yang WJ; Rao ZQ; Yang YN
    FASEB J; 2020 Aug; 34(8):10168-10181. PubMed ID: 32562311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
    Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
    Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.
    Zhong W; Fu J; Liao J; Ouyang S; Yin W; Liang Y; Liu K
    Int Urol Nephrol; 2024 Jun; 56(6):1987-1999. PubMed ID: 38097887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
    Su W; Wang H; Feng Z; Sun J
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype.
    Bao X; Liu X; Liu N; Zhuang S; Yang Q; Ren H; Zhao D; Bai J; Zhou X; Tang L
    Respir Res; 2021 Jul; 22(1):194. PubMed ID: 34217280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3/HIF-1α signaling activation mediates peritoneal fibrosis induced by high glucose.
    Yang X; Bao M; Fang Y; Yu X; Ji J; Ding X
    J Transl Med; 2021 Jun; 19(1):283. PubMed ID: 34193173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
    Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
    Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
    Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
    Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
    J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
    Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
    Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6
    Yang X; Yan H; Jiang N; Yu Z; Yuan J; Ni Z; Fang W
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F338-F353. PubMed ID: 31841386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
    Li L; Shen N; Wang N; Wang W; Tang Q; Du X; Carrero JJ; Wang K; Deng Y; Li Z; Lin H; Wu T
    Kidney Int; 2018 Jun; 93(6):1384-1396. PubMed ID: 29571940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.